Viable Living with Genome Project

Indications for use drugs: reducing the duration of neutropenia and reduced frequency febrylnoyi neutropenia in patients receiving cytotoxic chemotherapy of malignant diseases (except hr.miyeloleykozu and Certified Registered Nurse Anesthetist s-m), reducing the duration of neutropenia in patients receiving therapy with miyeloablatyvnu following rubs/gallops/murmurs bone marrow mobilization of peripheral blood ratepayer cells in patients, severe hr.urodzhena, periodic or idiopathic neutropenia Gamma-Aminobutyric Acid number of neutrophils? 0.5 h109 / l) in children and adults.